BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29318159)

  • 1. Randomized Control Trial for Reduction of Body Weight, Body Fat Patterning, and Cardiometabolic Risk Factors in Overweight Worksite Employees in Delhi, India.
    Shrivastava U; Fatma M; Mohan S; Singh P; Misra A
    J Diabetes Res; 2017; 2017():7254174. PubMed ID: 29318159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifestyle intervention reduces body weight and improves cardiometabolic risk factors in worksites.
    Salinardi TC; Batra P; Roberts SB; Urban LE; Robinson LM; Pittas AG; Lichtenstein AH; Deckersbach T; Saltzman E; Das SK
    Am J Clin Nutr; 2013 Apr; 97(4):667-76. PubMed ID: 23426035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial.
    Salas-Salvadó J; Díaz-López A; Ruiz-Canela M; Basora J; Fitó M; Corella D; Serra-Majem L; Wärnberg J; Romaguera D; Estruch R; Vidal J; Martínez JA; Arós F; Vázquez C; Ros E; Vioque J; López-Miranda J; Bueno-Cavanillas A; Tur JA; Tinahones FJ; Martín V; Lapetra J; Pintó X; Daimiel L; Delgado-Rodríguez M; Matía P; Gómez-Gracia E; Díez-Espino J; Babio N; Castañer O; Sorlí JV; Fiol M; Zulet MÁ; Bulló M; Goday A; Martínez-González MÁ;
    Diabetes Care; 2019 May; 42(5):777-788. PubMed ID: 30389673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences on effectiveness of a school-based physical activity intervention for reducing cardiometabolic risk: a cluster randomized trial.
    Martínez-Vizcaíno V; Sánchez-López M; Notario-Pacheco B; Salcedo-Aguilar F; Solera-Martínez M; Franquelo-Morales P; López-Martínez S; García-Prieto JC; Arias-Palencia N; Torrijos-Niño C; Mora-Rodríguez R; Rodríguez-Artalejo F
    Int J Behav Nutr Phys Act; 2014 Dec; 11():154. PubMed ID: 25491026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive dietary intervention promoting the Mediterranean diet in people with high cardiometabolic risk: a non-randomized study.
    Grimaldi M; Ciano O; Manzo M; Rispoli M; Guglielmi M; Limardi A; Calatola P; Lucibello M; Pardo S; Capaldo B; Riccardi G
    Acta Diabetol; 2018 Mar; 55(3):219-226. PubMed ID: 29218417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year weight loss maintenance outcomes following a worksite-based weight reduction program among Japanese men with cardiovascular risk factors.
    Tsukinoki R; Okamura T; Okuda N; Kadota A; Murakami Y; Yanagita M; Miyamatsu N; Miura K; Ueshima H
    J Occup Health; 2019 Mar; 61(2):189-196. PubMed ID: 30734418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Lifestyle Intervention on Cardiometabolic Risk Factors in Overweight and Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
    Khatlani K; Njike V; Costales VC
    Metab Syndr Relat Disord; 2019 Dec; 17(10):473-485. PubMed ID: 31513475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of the Modified Atherogenic Index of Plasma during Body Mass Reduction in Polish Obese/Overweight People.
    Zalejska-Fiolka J; Hubková B; Birková A; Veliká B; Puchalska B; Kasperczyk S; Błaszczyk U; Fiolka R; Bożek A; Maksym B; Mareková M; Birkner E
    Int J Environ Res Public Health; 2018 Dec; 16(1):. PubMed ID: 30591697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which Amount of BMI-SDS Reduction Is Necessary to Improve Cardiovascular Risk Factors in Overweight Children?
    Reinehr T; Lass N; Toschke C; Rothermel J; Lanzinger S; Holl RW
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3171-9. PubMed ID: 27285295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of metabolic syndrome in obese children before and after 1-year lifestyle intervention program.
    Pedrosa C; Oliveira BM; Albuquerque I; Simões-Pereira C; Vaz-de-Almeida MD; Correia F
    Eur J Nutr; 2011 Sep; 50(6):391-400. PubMed ID: 21107585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intermittent versus continuous calorie restriction on body weight and cardiometabolic risk markers in subjects with overweight or obesity and mild-to-moderate hypertriglyceridemia: a randomized trial.
    Maroofi M; Nasrollahzadeh J
    Lipids Health Dis; 2020 Oct; 19(1):216. PubMed ID: 33028352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.
    Thomson RL; Buckley JD; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3373-80. PubMed ID: 18583464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-initiated changes in physical activity levels improve cardiometabolic profiles: A longitudinal follow-up study.
    Ritti-Dias RM; Cucato GG; do Prado WL; Conceição RD; Santos RD; Bittencourt MS
    Nutr Metab Cardiovasc Dis; 2017 Jan; 27(1):48-53. PubMed ID: 27956022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect on the lipid parameters of an intervention to reduce weight in overweight and obese patients.
    Tárraga Marcos ML; Panisello Royo JM; Carbayo Herencia JA; Rosich Domenech N; Alins Presas J; Tárraga López PJ
    Clin Investig Arterioscler; 2017; 29(3):103-110. PubMed ID: 28318619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The results of a 2-year randomized trial of a worksite weight management intervention.
    Williams AE; Stevens VJ; Albright CL; Nigg CR; Meenan RT; Vogt TM
    Am J Health Promot; 2014; 28(5):336-9. PubMed ID: 24524385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Liquid Meal Replacements on Cardiometabolic Risk Factors in Overweight/Obese Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Noronha JC; Nishi SK; Braunstein CR; Khan TA; Blanco Mejia S; Kendall CWC; Kahleová H; Rahelić D; Salas-Salvadó J; Leiter LA; Sievenpiper JL
    Diabetes Care; 2019 May; 42(5):767-776. PubMed ID: 30923163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of improvement in cardiometabolic risk factors with weight loss in women.
    Dow CA; Thomson CA; Flatt SW; Sherwood NE; Pakiz B; Rock CL
    J Am Heart Assoc; 2013 Dec; 2(6):e000152. PubMed ID: 24351700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight-Loss Diets, Adiponectin, and Changes in Cardiometabolic Risk in the 2-Year POUNDS Lost Trial.
    Ma W; Huang T; Zheng Y; Wang M; Bray GA; Sacks FM; Qi L
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2415-22. PubMed ID: 27055193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.
    Pi-Sunyer FX; Aronne LJ; Heshmati HM; Devin J; Rosenstock J;
    JAMA; 2006 Feb; 295(7):761-75. PubMed ID: 16478899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between neck circumference, insulin resistance and arterial stiffness in overweight and obese subjects.
    Fantin F; Comellato G; Rossi AP; Grison E; Zoico E; Mazzali G; Zamboni M
    Eur J Prev Cardiol; 2017 Sep; 24(14):1532-1540. PubMed ID: 28728486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.